Literature DB >> 25431903

Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population.

Naomi Ochieng'1, Humphrey Okechi, Susan Ferson, A Leland Albright.   

Abstract

OBJECT: Ventriculoperitoneal shunt (VPS) infections are a major cause of morbidity and mortality in patients with hydrocephalus. Most data about these infections come from the Western literature. Few data about infecting organisms in Africa are available, yet knowledge of these organisms is important for the prevention and treatment of infectious complications. The purpose of this study was to determine the organisms cultured from infected shunts in a rural Kenyan hospital.
METHODS: The authors conducted a retrospective study of patients with VPS infections recorded in the neurosurgical database of BethanyKids at Kijabe Hospital between September 2010 and July 2012.
RESULTS: Among 53 VPS infections confirmed by culture, 68% occurred in patients who were younger than 6 months. Seventy-nine percent of the infections occurred within 2 months after shunt insertion. Only 51% of infections were caused by Staphylococcus species (Staphylococcus aureus 25%, other Staphylococcus species 26%), whereas 40% were caused by gram-negative bacteria. All S. aureus infections and 79% of other Staphylococcus infections were sensitive to cefazolin, but only 1 of 21 gram-negative bacteria was sensitive to it. The majority of gram-negative bacterial infections were multidrug resistant, but 17 of the 20 gram-negative bacteria were sensitive to meropenem. Gram-negative bacterial infections were associated with worse outcomes.
CONCLUSIONS: The high proportion of gram-negative infections differs from data in the Western literature, in which Staphylococcus epidermidis is by far the most common organism. Once a patient is diagnosed with a VPS infection in Kenya, immediate treatment is recommended to cover both gram-positive and gram-negative bacterial infections. Data from other Sub-Saharan countries are needed to determine if those countries have the same increased frequency of gram-negative infections.

Entities:  

Keywords:  EVD = external ventricular drain; ICP = intracranial pressure; VP shunt infections; VPS = ventriculoperitoneal shunt; WBC = white blood cell; antibiotics; bacteria; hydrocephalus

Mesh:

Substances:

Year:  2014        PMID: 25431903     DOI: 10.3171/2014.10.PEDS14178

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  5 in total

1.  Edaravone reduces astrogliosis and apoptosis in young rats with kaolin-induced hydrocephalus.

Authors:  Camila Araújo Bernardino Garcia; Carlos Henrique Rocha Catalão; Hélio Rubens Machado; Ivair Matias Júnior; Thais Helena Romeiro; José Eduardo Peixoto-Santos; Marcelo Volpon Santos; Luiza da Silva Lopes
Journal:  Childs Nerv Syst       Date:  2016-12-17       Impact factor: 1.475

2.  Neurosurgical management of hydrocephalus by a general surgeon in an extremely low resource setting: initial experience in North Kivu province of Eastern Democratic Republic of Congo.

Authors:  Sarah B Cairo; Justice Agyei; Kavira Nyavandu; David H Rothstein; Luc Malemo Kalisya
Journal:  Pediatr Surg Int       Date:  2018-02-16       Impact factor: 1.827

3.  A Retrospective Study on the Avoidability of Ventriculoperitoneal Shunt Infections in a University Hospital in Al-Khobar, Saudi Arabia.

Authors:  Maan A Albehair; Mazen A Alosail; Naif M Albulwi; Ahmed AlAssiry; Fahad A Alzahrani; Ammar Bukhamsin; Ahmed Ammar
Journal:  Cureus       Date:  2021-02-04

4.  Antimicrobial resistance in Africa: a systematic review.

Authors:  Birkneh Tilahun Tadesse; Elizabeth A Ashley; Stefano Ongarello; Joshua Havumaki; Miranga Wijegoonewardena; Iveth J González; Sabine Dittrich
Journal:  BMC Infect Dis       Date:  2017-09-11       Impact factor: 3.667

5.  Rates of cerebrospinal fluid infection and the causative organisms following shunt procedures in Saudi Arabia. A retrospective study based on radiological findings.

Authors:  AbdulAziz M Al-Sharydah; Yaser A Abu Melha; Sari S Al-Suhibani; Abdulrazaq A Alojan; Tareq H Al-Taei; Iba I Alfawaz; Lateefah T AlShammari; Saeed A Al-Jubran; Ahmed S Ammar
Journal:  Saudi Med J       Date:  2020-06       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.